Access cutting-edge vaccination; infection treatment through this clinical trial at a research site in Brooklyn. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Brooklyn location
Preparing your pre-screening questions…
Access vaccination; infection specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related vaccination; infection treatment provided free
Check if you qualify for this vaccination; infection clinical trial in Brooklyn, NY
No-Cost Study Care
Local to Brooklyn
Convenient for NY residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
SWIFT-ID-101 is a single site survey study designed to assess potential participants' eligibility to screen for industry-sponsored clinical trials for diagnosis, treatment, or prevention of infectious diseases such as in the areas of HIV, vaccines, and other infectious-diseases areas. A physician will oversee the informed consent process, after which participants will be surveyed on demographics, medical/surgical history, physical examination, comorbidities, and any current symptoms. Informed consent will be done electronically (preferable) or on paper. Informed consent may be done in-person or remotely, depending on patient preference. Information related to HIV, hepatitis B and C, other infectious diseases, or substance use disorder will also be obtained if applicable. Site staff may collect vital signs, fingerpick testing, urine drug screens, blood draws, EKG, and pregnancy tests. Some testing may be recommended in a fasting condition. A doctor will review medical history and results of the above evaluations with the participant to determine study suitability via clinical interview. The doctor may reach out to the patient's current treating physicians, other providers, and pharmacies to determine eligibility for clinical trials. A follow-up phone call may be needed to discuss testing results and/or trial eligibility. If a participant is deemed eligible for future trials and if the participant remains interested, counseling on contraception requirements for trials will be discussed.
Sponsor: Brooklyn Clinical Research
Yes, this clinical trial (NCT06492187) has an active research site in Brooklyn, NY that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for vaccination; infection treatment options in Brooklyn, NY, this clinical trial (NCT06492187) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Brooklyn research site is actively enrolling participants for this clinical trial. You'll receive care from experienced vaccination; infection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all vaccination; infection clinical trials near you to find additional studies recruiting in your area.
See all vaccine clinical trials recruiting in Brooklyn — not just this study.
Browse Vaccine Trials in Brooklyn →